leading glp-1 treatments for diabetes 2025 What is the pipeline future medications for obesity? GLP-1s in 2025: Who's Using

3 These findings move GLP-1s out of the weight-loss drug category and into the category of proven cardiovascular risk-reduction tools

For patients with type 2 diabetes, blood glucose improvements become apparent within weeks, with hemoglobin A1c reductions evident after 12 to 16 weeks

Probiotics : Early research suggests that probioticslive microorganisms in your digestive systemmay promote cells in the intestines to secrete GLP-1, thus improving insulin function

GLP-1 weight loss injections are typically recommended for individuals who: Have a Body Mass Index (BMI) of 30 or higher (obesity) or a BMI of 27 or higher with an obesity-related condition (like type 2 diabetes, hypertension, or high cholesterol), have difficulty losing weight through diet and exercise alone, have type 2 diabetes and need better blood sugar control along with weight management